Related Experiment Videos
Antioxidants in cardiovascular disease: randomized trials
1Department of Medicine, Brigham and Women's Hospital, Boston, MA 02215-1204, USA.
Nutrition (Burbank, Los Angeles County, Calif.)
|September 1, 1996
Summary
Antioxidant vitamins like C and E may reduce cardiovascular disease risk, but evidence from randomized trials is inconsistent. More research is needed to determine their true benefits and risks for preventing heart disease and cancer.
Area of Science:
- Nutritional Science
- Cardiovascular Research
- Preventive Medicine
Background:
- Observational studies link high fruit and vegetable intake to lower cardiovascular disease (CVD) and cancer rates.
- Antioxidants in fruits and vegetables are hypothesized to explain these protective effects.
- Basic research suggests a plausible mechanism for antioxidants reducing atherosclerosis risk.
Purpose of the Study:
- To evaluate the role of antioxidant vitamins (C, E, beta-carotene) in the primary prevention of cardiovascular disease.
- To synthesize findings from observational studies and randomized controlled trials (RCTs) on antioxidant supplements and CVD risk.
Main Methods:
- Review of basic research, epidemiologic studies (descriptive, case-control, cohort), and large-scale randomized trials of antioxidant supplements.
- Analysis of data on the association between antioxidant vitamin consumption and CVD risk.
Main Results:
- Epidemiologic data suggest an association between antioxidant vitamin consumption and reduced CVD risk.
- Results from major RCTs on antioxidant supplements are inconsistent, neither proving nor disproving their benefit.
- Some RCTs suggest potential overestimation of benefits from observational studies and possible adverse effects.
Conclusions:
- Current RCT data are insufficient to definitively assess the risk-benefit ratio of antioxidant supplements for CVD prevention.
- Further research is required to clarify the role of antioxidants in preventing atherosclerotic disease and cancer.
- Antioxidant supplements' role in primary and secondary CVD prevention remains uncertain pending more robust data.